These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6136141)

  • 41. Clonidine-induced growth hormone and growth-hormone-releasing hormone release is mediated by tachykinin NK2 receptors in sheep.
    Lemamy GJ; Guillaume V; Ndéboko B; Mouecoucou J; Renard M; Oliver C
    Pharmacology; 2012; 89(5-6):270-4. PubMed ID: 22517235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Failure of naloxone to modify the inhibitory effect of clonidine on insulin secretion.
    Massara F; Limone P; Tagliabue M; Molinatti GM
    J Endocrinol Invest; 1983 Feb; 6(1):67-8. PubMed ID: 6341443
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
    Cordido F; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Possible role of an endogenous opiate in the cardiovascular effects of central alpha adrenoceptor stimulation in spontaneously hypertensive rats.
    Farsang C; Ramirez-Gonzalez MD; Mucci L; Kunos G
    J Pharmacol Exp Ther; 1980 Jul; 214(1):203-8. PubMed ID: 6248627
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of sleep deprivation on the growth hormone response to the alpha-3 adrenergic receptor agonist, clonidine, in normal subjects.
    Lal S; Thavundayil JX; Krishnan B; Nair NP; Schwartz G; Kiely ME; Guyda H
    J Neural Transm (Vienna); 1997; 104(2-3):291-8. PubMed ID: 9203090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Naloxone does not modify the hemodynamic and neuroendocrine effects of clonidine in normal humans.
    Pedrinelli R; Bernini GP; Salvetti A
    J Cardiovasc Pharmacol; 1985; 7(5):953-7. PubMed ID: 2413307
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of estrogen on the growth hormone response to the alpha-adrenergic agonist clonidine in women with menopausal flushing.
    Tulandi T; Lal S; Guyda H
    J Clin Endocrinol Metab; 1987 Jul; 65(1):6-10. PubMed ID: 2884230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Noradrenergic receptor sensitivity in obsessive-compulsive disorders: I. Growth hormone response to clonidine stimulation.
    Brambilla F; Perna G; Bellodi L; Arancio C; Bertani A; Perini G; Carraro C; Gava F
    Psychiatry Res; 1997 Mar; 69(2-3):155-62. PubMed ID: 9109183
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impairment of adrenergic-induced proopiomelanocortin-related peptide release in heroin addicts.
    Facchinetti F; Volpe A; Nappi G; Petraglia F; Genazzani AR
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):1-5. PubMed ID: 2857510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of naloxone on basal and stimulated insulin secretion in the mouse.
    Ahrén B; Lundquist I
    Eur J Pharmacol; 1984 Jun; 102(1):135-9. PubMed ID: 6090153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The peripheral action of clonidine analog ST-91: involvement of atrial natriuretic factor.
    Gutkowska J; Mukaddam-Daher S; Tremblay J
    J Pharmacol Exp Ther; 1997 May; 281(2):670-6. PubMed ID: 9152372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence for a primary involvement of somatostatin in clonidine-induced growth hormone release in conscious rats.
    Lanzi R; Lapointe M; Gurd W; Tannenbaum GS
    J Endocrinol; 1994 May; 141(2):259-66. PubMed ID: 7913948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined alpha-adrenergic stimulation results in biphasic response of growth hormone release in man.
    Iovino M; Monteleone P; Steardo L
    J Clin Endocrinol Metab; 1988 Jan; 66(1):217-20. PubMed ID: 2826526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Naloxone does not affect the cardiovascular, sedative or neurohormonal effects of clonidine in normal and hypertensive man.
    Mathias CJ; da Costa DF; Cleary JC; Peart S
    J Hypertens Suppl; 1985 Dec; 3(4):S77-9. PubMed ID: 3007707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma growth hormone responses to microinfusion of noradrenergic agents into or electrical stimulation of the hypothalamus and amygdala in baboons.
    McWilliam JR; Meldrum BS
    Horm Metab Res; 1985 Sep; 17(9):443-7. PubMed ID: 2995219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of endogenous cholinergic tone and alpha-adrenergic pathways on growth hormone responses to His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in the dog.
    Muruais J; Peñalva A; Dieguez C; Casanueva FF
    J Endocrinol; 1993 Aug; 138(2):211-8. PubMed ID: 8228729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Guanfacine as an alpha-2-agonist inducer of growth hormone secretion--a comparison with clonidine.
    Balldin J; Berggren U; Eriksson E; Lindstedt G; Sundkler A
    Psychoneuroendocrinology; 1993; 18(1):45-55. PubMed ID: 8097332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased growth hormone response to clonidine in 6-hydroxydopamine-treated rats.
    Siever LJ; Tamminga C; Pert A
    Psychopharmacology (Berl); 1987; 91(3):342-4. PubMed ID: 3104956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antinociceptive interactions between alpha 2-adrenergic and opiate agonists at the spinal level in rodents.
    Ossipov MH; Suarez LJ; Spaulding TC
    Anesth Analg; 1989 Mar; 68(3):194-200. PubMed ID: 2537587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.